VISFO
Success story

Strategic clarity for Phase 3 and beyond

Bridging data gaps to shape smarter trials and build confidence in future positioning across clinical and commercial teams.
Credit card mockupColorful gradient

At a glance

Pharmaceutical

Market Access

Value communication

Initial delivery in 4 weeks

Delivered through HelixAI

Ongoing engagement

"With VISFO’s precision intelligence and collaborative approach, our team ensures you have the right insights, at the right time, to make the best possible strategic decisions."

Dr. Rachael Hagan
Director of Product

“What made the difference was the ability to connect clinical, epidemiological, and digital signals into one decision-making view. That’s how you move from insight to strategic advantage.”

Dr. Louise Street-Docherty
VP Strategic Intelligence

“What made the difference was the ability to connect clinical, epidemiological, and digital signals into one decision-making view. That’s how you move from insight to strategic advantage.”

Dr. Max Nobile
CEO

“With deep research roots and peer-reviewed expertise in digital insight, we help teams cut through noise to uncover what truly shapes outcomes, ensuring every decision is informed by what matters most.”

Dr Adam Poulston
Director of Engineering

“With deep research roots and peer-reviewed expertise in digital insight, we help teams cut through noise to uncover what truly shapes outcomes, ensuring every decision is informed by what matters most.”

Dr. Simon Leigh
Director of Research & Insights
Strategic clarity for Phase 3 and beyond

Built on data, shaped by expertise

Combining sharp data science, deep industry knowledge, and the tools to move fast and make it stick

The challenge

The drug showed promise, but the client lacked the insight to confidently design a trial that would differentiate their asset and drive approval. They needed to understand disease prevalence, key clinical and commercial benchmarks, and who was shaping opinion in the space. Time was short and decisions couldn’t wait.

The analysis

We began by building a comprehensive clinical landscape, synthesizing data from literature reviews, publication databases, competitive trial registries, pricing intelligence, and real-world signals from digital sources.

Our data science team created custom dashboards to visualize incidence, prevalence, and risk factors, layered by geography and demographic. We mapped KOLs based on publication activity and digital influence, identified gaps in the treatment landscape, and conducted social listening to monitor competitor sentiment and emerging concerns around adverse events.

Each element was delivered through a collaborative insight board tailored to their strategic questions. This allowed for rapid exploration and alignment across the client’s R&D, medical, and commercial teams.

The solution

The client received a bespoke, integrated intelligence board designed to support both immediate trial design and long-term positioning. They could explore the epidemiology and market context in detail, understand how their asset fit within the treatment paradigm, and identify strategic opportunities to stand out.

We helped them understand not just what the data said, but why it mattered and how to act on it.

The value to the client

The insights empowered the client to refine their Phase 3 trial strategy with confidence. They could choose trial endpoints aligned to unmet need, engage the right KOLs, and begin developing a more credible narrative for regulators and investors. What started as a data gap became a source of strategic strength.

Ongoing support

We continued to support the client by transforming the initial board into a live, always-available platform. It now serves as a cross-functional reference tool for their clinical, medical, and commercial teams, helping them stay alert to competitor shifts, publication trends, and evolving stakeholder sentiment as the asset progresses.

Build your solution

Take a guided walkthrough of how we solve complex challenges, step by step. Just tell us what you’re facing, and we’ll show you how data science, expert insight, and software come together to deliver lasting results.
Dashboard mockupiPhone mockup
Testimonals

What our clients say about us

"This is allowing me to answer questions I didn’t even know I had"
Medical Affairs Director
"I haven't seen anything like it with any other consulting group, ever."
VP Market Access & Reimbursement
"Thank you VISFO, this is incredible value for money"
Global Market Access Director
"The stakeholder mapping means I know how to resource my MSLs"
US Medical New Product Planning
"You have demonstrated all that I thought wasn’t possible"
Senior Director
This is allowing me to answer questions I didn’t even know I had!”
Medical Affairs Director
"Thank you VISFO, this is incredible value for money."
Global Market Access Director
"The stakeholder mapping means I know how to resource my MSLs."
US Medical New Product Planning
"You have demonstrated all that I thought wasn’t possible."
Senior Director